-

Data Integrity and Document Management Training Course: Ensure Compliance with Latest Data Integrity Guidelines (ONLINE EVENT: July 14, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Data Integrity and Document Management Training Course" has been added to ResearchAndMarkets.com's offering.

This course is designed for managers and staff from all GxP areas in the pharmaceutical and medical device industries who are responsible for the creation, review, approval and/or reporting of data to ensure data integrity.

Document management and data integrity have become focal points during regulatory inspections by both EU and FDA authorities, with a notable increase in violation observations in GxP inspections. This highlights the critical nature of document governance. Regulatory bodies mandate that individuals in GxP roles be well-versed in this area, underscoring its significance in maintaining drug safety, efficacy, and quality.

Recent regulatory actions, including warning letters and critical inspection findings, have often stemmed from breaches in document management and data integrity. As a response, the FDA, EMA, MHRA, and the World Health Organization (WHO) have released new guidelines aimed at fortifying data integrity within the pharma sector.

This comprehensive course delves into the imperatives of data integrity, highlighting its impacts on both paper-based and digital systems. Participants will engage with the latest MHRA data integrity and EMA TMF guidelines crucial for any entity engaged in the GxP pharmaceutical lifecycle, covering facets of GCP, GMP, GLP, and GvP.

Attendees will gain insights into ensuring compliance with data integrity standards. The program offers a detailed review of data integrity inspection findings and provides hands-on advice on setting up a robust data governance process to meet compliance demands.

Benefits of Attending:

  • Grasp the significance of data integrity and best practices in document management.
  • Achieve compliance with the new EU trial master file (TMF) guideline.
  • Stay informed about pivotal regulations and directives.
  • Deliberate on QMS considerations related to data integrity and document management.
  • Explore inspection outcomes on document management and data integrity for better regulatory compliance.
  • Understand governance requirements to avert data integrity breaches effectively.
  • This course is part of the GxP training collection, covering various topics to maintain adherence to regulatory and quality standards.

Certification:

  • CPD: Earn 6 hours towards your professional development records.
  • Receive a certificate of completion upon the course's conclusion.

Who Should Attend:

  • Clinical trials
  • Manufacturing
  • Quality assurance/quality control
  • Compliance
  • Pharmacovigilance

Key Topics Covered:

Principles of data integrity and good documentation practice

  • What is data integrity?
  • Why is data integrity important?
  • ALCOA principles
  • Good documentation practice including paper and electronic records

Data integrity regulations and guidelines

  • MHRA/WHO/FDA/EMA/PICS/ICH GCP R2 data integrity guidelines
  • Group review and discussion of some key regulated documents

Document management and data integrity inspection findings

  • MHRA, EMA findings, EU non-compliance reports
  • FDA findings
  • Group discussion on inspection findings

QMS considerations for Data integrity and documentation

  • Elements of QMS for data integrity
  • Risk management considerations
  • Data governance
  • Discussion of participants experience and best practice

Data integrity for computer systems

  • Computer system validation considerations
  • Compliance expectations for GxP systems

Discussion of document and data integrity issues

  • Data integrity and digital signatures
  • Certified copies/true copies
  • Managing and preventing data integrity breaches

For more information about this training visit https://www.researchandmarkets.com/r/hj86ci

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The UAE automotive spare parts e-commerce market, valued at USD 1.2 billion, is experiencing a robust expansion influenced by the surge in online shopping, vehicle ownership, and the need for cost-effective solutions. The convenience provided by e-commerce platforms is r...

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...
Back to Newsroom